At 5mg per week with a 5mg/ml concentration, you are drawing 100 units, a full syringe
The subjects used for this study were six-month-old male F344BN rats, originally obtained from the National Institute on Aging Colony at Charles River Laboratories
Administered as a once-weekly injection under medical supervision, they offer a non-surgical option for patients looking for additional support in their weight management journey

Potential Research Benefits Investigates multiple metabolic hormone pathways simultaneously Supports obesity and metabolic research studies Helps researchers study appetite and satiety signaling Provides insight into glucose regulation mechanisms Supports investigation of energy balance and body composition High-purity peptide format for laboratory research How Retatrutide Works Retatrutide combines three mechanisms into one peptide: GLP-1 Pathway Research focuses on GLP1 activity involved in: Appetite signaling Satiety response Gastric emptying regulation Glucose-dependent insulin release GIP Pathway Research focuses on GIP activity involved in: Insulin regulation Nutrient metabolism Hormonal signaling Glucagon Pathway Research focuses on glucagon activity involved in: Energy expenditure Metabolic rate regulation Fat utilization pathways The combination of these three pathways makes Retatrutide different from single- or dual-pathway metabolic peptides currently being studied

In a chemically induced colon cancer model using 1,2-dimethylhydrazine (DMH), rats received Epitalon treatment before, during, and after carcinogen exposure